Haselmeier
Schelmenwasenstrasse 14, Stuttgart, Baden-Wurttemberg, 70567, Germany
Overview
Haselmeier is a leading developer and manufacturer of innovative self-injection devices featuring proprietary designs, technology and intellectual property. With over four decades of medical device experience, Haselmeier has built up a world class Design and Development Team – working in compliance with regulatory requirements – for the creation, design and industrialization of their innovative self-injection systems used by pharmaceutical and biotechnology companies worldwide. Headquartered in Switzerland, the Haselmeier Group employs approximately 200 team members worldwide and has a presence in Europe, United States, India and China. Products are manufactured at state-of-the-art manufacturing sites located in Buchen im Odenwald (Germany), Dnesice (Czech Republic) and Bangaluru (India).
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Biotechnology
- Manufacturing
- Medical Device
Investment portfolio
- Common Sensing
Participated · Series A · Apr 2018
Common Sensing is a Cambridge, MA-based, evidence-based, data-driven injectable-medicine healthcare company founded in 2012. It was co-founded by James White and Richard Whalley and is led operationally by COO Kevin Schmid. The company is advancing Gocap, an IP-protected smart cap that tracks, logs and manages injectable dosage, timing, and storage to provide a complete picture of how people use injectable medicine at home and on the go. Gocap enables patients and providers to utilize injectable medicines including insulin, fertility medications, and growth hormones. Common Sensing offers data-driven services such as remote disease management, pharmaceutical support, automatic refills, dose titration, and caretaker collaboration. It recently closed a $6.6M Series A to accelerate manufacturing and commercial operations for Gocap.